Haemonetics Corporation Restructuring and Related Cost, Cost Incurred to Date
Haemonetics Corporation (HAE) had Restructuring and Related Cost, Cost Incurred to Date of $77.00 million as of 2024-03-30, per its 10-K filed 2024-05-20.
Discontinued › Notes › Restructuring and Related Activities › Restructuring and Related Cost, Expected Cost
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2024-05-20
- 2024-03-30: Restructuring and Related Cost, Cost Incurred to Date $77.00M.
- 2023-04-01: Restructuring and Related Cost, Cost Incurred to Date $67.20M.
- 2022-04-02: Restructuring and Related Cost, Cost Incurred to Date $55.70M.
- 2021-04-03: Restructuring and Related Cost, Cost Incurred to Date $27.00M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2024-03-30 | $77.00M 10-K · filed 2024-05-20 |
| 2023-04-01 | $67.20M 10-K · filed 2023-05-22 |
| 2022-04-02 | $55.70M 10-K · filed 2022-05-25 |
| 2021-04-03 | $27.00M 10-K · filed 2021-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |